Edward Stites, MD, PhD
Assistant Professor
Integrative Biology Laboratory
Hearst Foundation Developmental Chair
Assistant Professor
Integrative Biology Laboratory
Hearst Foundation Developmental Chair
LA JOLLA—Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. …
LA JOLLA—For the past fifteen years, cancer researchers have been using DNA sequencing technology to identify the gene mutations that cause different forms of cancer. Now, Salk Assistant Professor Edward …
LA JOLLA—Salk Professor Thomas Albright has been awarded $1 million and Assistant Professor Edward Stites awarded $500,000 by The Conrad Prebys Foundation as part of its inaugural round of grants. …
LA JOLLA—Salk Institute Assistant Professor Edward Stites has been named an NIH Director’s New Innovator for 2020 as part of the National Institutes of Health’s High-Risk, High-Reward Research Program. The award “supports …
LA JOLLA—Colorectal cancer is a common lethal disease, and treatment decisions are increasingly influenced by which genes are mutated within each patient. Some patients with a certain gene mutation benefit …
LA JOLLA—The Salk Institute is pleased to welcome Wolfgang Busch as an associate professor and Edward Stites as an assistant professor, leaders of plant science and cancer research, respectively.
“Salk’s mission …
BS, Mathematics, University Of Kentucky, Lexington
MD, University Of Virginia, Charlottesville
PhD, Biophysics, University Of Virginia, Charlottesville
Residency, Clinical Pathology, Washington University, St. Louis
